High Deviation rates between local and central HER2 assessment and survival with anti-HER2-therapy in advanced Gastric Cancer (GC): Results from the VARIANZ study

F Lordick; I Haffner; B Luber; D Maier; B Geier; E Raimundez; J Hasenauer; A Kretzschmar; LF von Weikersthal; M Ahlborn; J Riera; B Rau; Gabriele Siegler; S Fuxius; T Decker; K Schierle; C Wittekind

High Deviation rates between local and central HER2 assessment and survival with anti-HER2-therapy in advanced Gastric Cancer (GC): Results from the VARIANZ study

F Lordick, I Haffner, B Luber, D Maier, B Geier, E Raimundez, J Hasenauer, A Kretzschmar, LF von Weikersthal, M Ahlborn, J Riera, B Rau, Gabriele Siegler, S Fuxius, T Decker, K Schierle, C Wittekind

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	191-191
Journal	Oncology Research and Treatment
Volume	41
Publication status	Published - 2018

Cite this

Lordick, F., Haffner, I., Luber, B., Maier, D., Geier, B., Raimundez, E., Hasenauer, J., Kretzschmar, A., von Weikersthal, LF., Ahlborn, M., Riera, J., Rau, B., Siegler, G., Fuxius, S., Decker, T., Schierle, K., & Wittekind, C. (2018). High Deviation rates between local and central HER2 assessment and survival with anti-HER2-therapy in advanced Gastric Cancer (GC): Results from the VARIANZ study. Oncology Research and Treatment, 41, 191-191.

@article{22181da8503344e0b39190924a8f4883,

title = "High Deviation rates between local and central HER2 assessment and survival with anti-HER2-therapy in advanced Gastric Cancer (GC): Results from the VARIANZ study",

author = "F Lordick and I Haffner and B Luber and D Maier and B Geier and E Raimundez and J Hasenauer and A Kretzschmar and {von Weikersthal}, LF and M Ahlborn and J Riera and B Rau and Gabriele Siegler and S Fuxius and T Decker and K Schierle and C Wittekind",

year = "2018",

language = "English",

volume = "41",

pages = "191--191",

journal = "Oncology Research and Treatment",

issn = "2296-5270",

}

Lordick, F, Haffner, I, Luber, B, Maier, D, Geier, B, Raimundez, E, Hasenauer, J, Kretzschmar, A, von Weikersthal, LF, Ahlborn, M, Riera, J, Rau, B, Siegler, G, Fuxius, S, Decker, T, Schierle, K & Wittekind, C 2018, 'High Deviation rates between local and central HER2 assessment and survival with anti-HER2-therapy in advanced Gastric Cancer (GC): Results from the VARIANZ study', Oncology Research and Treatment, vol. 41, pp. 191-191.

TY - JOUR

T1 - High Deviation rates between local and central HER2 assessment and survival with anti-HER2-therapy in advanced Gastric Cancer (GC): Results from the VARIANZ study

AU - Lordick, F

AU - Haffner, I

AU - Luber, B

AU - Maier, D

AU - Geier, B

AU - Raimundez, E

AU - Hasenauer, J

AU - Kretzschmar, A

AU - von Weikersthal, LF

AU - Ahlborn, M

AU - Riera, J

AU - Rau, B

AU - Siegler, Gabriele

AU - Fuxius, S

AU - Decker, T

AU - Schierle, K

AU - Wittekind, C

PY - 2018

Y1 - 2018

M3 - Abstract (Journal)

SN - 2296-5270

VL - 41

SP - 191

EP - 191

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

ER -